Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Leflunomide industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
HERITAGE
ALEMBIC
HUITIAN
Apote
MERRO
YABANG
Teva
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Type 1
Type 2
Type 3
Application:
Application 1
Application 2
Application 3
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Leflunomide Industry Overview
-
1.1.1 Leflunomide Market Scope and Market Segments
-
1.1.2 Leflunomide Industry Characteristics
-
1.1.3 Global and China Leflunomide Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Leflunomide Production Value and Growth Rate (2017-2028)
-
1.2 Global Leflunomide Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Type 1
-
1.2.2 Type 2
-
1.2.3 Type 3
-
1.3 Global Leflunomide Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Application 1
-
1.3.2 Application 2
-
1.3.3 Application 3
-
1.4 Market Analysis by Region
-
1.4.1 North America Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Leflunomide Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Leflunomide Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Leflunomide Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Leflunomide Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Leflunomide Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Leflunomide Industry Porter's Five Forces Model Analysis
-
2.2.3 Leflunomide Industry PEST Analysis
-
2.3 Leflunomide Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Leflunomide Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Leflunomide Industry
Chapter 3 Global and China Leflunomide Market, by Manufacturer
-
3.1 Global and China Leflunomide Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Leflunomide Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Leflunomide Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Leflunomide Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Leflunomide Market Top 3 Players
Chapter 4 Global and China Leflunomide Market, by Type (2017-2028)
-
4.1 Leflunomide Market Trend, by Type
-
4.2 Global Leflunomide Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Leflunomide Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Leflunomide Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Leflunomide Price Trend, by Type (2017-2028)
-
4.3 China Leflunomide Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Leflunomide Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Leflunomide Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Leflunomide Price Trend, by Type (2017-2028)
Chapter 5 Global and China Leflunomide Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Leflunomide Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Leflunomide Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Leflunomide Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Leflunomide Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Leflunomide Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Leflunomide Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Leflunomide Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Leflunomide Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Leflunomide Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Leflunomide Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Leflunomide Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Leflunomide Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Leflunomide Market Analysis
-
7.1 North America Leflunomide Market, by Type
-
7.2 North America Leflunomide Market, by Application
-
7.3 North America Leflunomide Market Analysis and Forecast, by Country
-
7.3.1 United States Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Leflunomide Market Analysis
-
8.1 Europe Leflunomide Market, by Type
-
8.2 Europe Leflunomide Market, by Application
-
8.3 Europe Leflunomide Market Analysis and Forecast, by Country
-
8.3.1 Germany Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Leflunomide Market Analysis
-
9.1 APAC Leflunomide Market, by Type
-
9.2 APAC Leflunomide Market, by Application
-
9.3 APAC Leflunomide Market Analysis and Forecast, by Country
-
9.3.1 China Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Leflunomide Market Analysis
-
10.1 Latin America, Middle East and Africa Leflunomide Market, by Type
-
10.2 Latin America, Middle East and Africa Leflunomide Market, by Application
-
10.3 Latin America, Middle East and Africa Leflunomide Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Leflunomide Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Leflunomide Company Profiles
-
11.1 HERITAGE
-
11.1.1 HERITAGE Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 HERITAGE Leflunomide Product Profiles, Application and Specification
-
11.1.3 HERITAGE Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 ALEMBIC
-
11.2.1 ALEMBIC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 ALEMBIC Leflunomide Product Profiles, Application and Specification
-
11.2.3 ALEMBIC Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 HUITIAN
-
11.3.1 HUITIAN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 HUITIAN Leflunomide Product Profiles, Application and Specification
-
11.3.3 HUITIAN Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Apote
-
11.4.1 Apote Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Apote Leflunomide Product Profiles, Application and Specification
-
11.4.3 Apote Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 MERRO
-
11.5.1 MERRO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 MERRO Leflunomide Product Profiles, Application and Specification
-
11.5.3 MERRO Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 YABANG
-
11.6.1 YABANG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 YABANG Leflunomide Product Profiles, Application and Specification
-
11.6.3 YABANG Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Teva
-
11.7.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Teva Leflunomide Product Profiles, Application and Specification
-
11.7.3 Teva Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Leflunomide Industry Investment Prospect and Risk Assessment
-
12.1 Leflunomide Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Leflunomide Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure China Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Global Leflunomide Production Value and Growth Rate (2017-2028)
-
Figure China Leflunomide Production Value and Growth Rate (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Type 1 (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Type 2 (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Type 3 (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Application 1 (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Application 2 (2017-2028)
-
Figure Global Leflunomide Market Size and Growth Rate of Application 3 (2017-2028)
-
Figure North America Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Leflunomide Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Leflunomide Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Leflunomide Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Leflunomide Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Leflunomide Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Leflunomide Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Leflunomide Market Share, by Manufacturer in 2021
-
Figure Global and China Leflunomide Market Share, by Manufacturer in 2022
-
Table Global Leflunomide Sales Volume, by Type (2017-2028)
-
Table Global Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure Global Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table Global Leflunomide Sales Value, by Type (2017-2028)
-
Table Global Leflunomide Sales Value Share, by Type (2017-2028)
-
Figure Global Leflunomide Price Trend, by Type (2017-2028)
-
Table China Leflunomide Sales Volume, by Type (2017-2028)
-
Table China Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure China Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table China Leflunomide Sales Value, by Type (2017-2028)
-
Table China Leflunomide Sales Value Share, by Type (2017-2028)
-
Figure China Leflunomide Price Trend, by Type (2017-2028)
-
Table Global Leflunomide Sales Volume, by Application (2017-2028)
-
Table Global Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure Global Leflunomide Sales Volume Share, by Application (2017-2028)
-
Table Global Leflunomide Sales Value, by Application (2017-2028)
-
Table Global Leflunomide Sales Value Share, by Application (2017-2028)
-
Figure Global Leflunomide Sales Value Share, by Application (2017-2028)
-
Table China Leflunomide Sales Volume, by Application (2017-2028)
-
Table China Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure China Leflunomide Sales Volume Share, by Application (2017-2028)
-
Table China Leflunomide Sales Value, by Application (2017-2028)
-
Table China Leflunomide Sales Value Share, by Application (2017-2028)
-
Figure China Leflunomide Sales Value Share, by Application (2017-2028)
-
Figure China Leflunomide Production, Import, Consumption and Export (2017-2022)
-
Figure North America Leflunomide Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Leflunomide Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Leflunomide Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Leflunomide Production, Import, Consumption and Export (2017-2022)
-
Table North America Leflunomide Sales Volume, by Type (2017-2028)
-
Table North America Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure North America Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table North America Leflunomide Sales Volume, by Application (2017-2028)
-
Table North America Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure North America Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure United States Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure United States Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Canada Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Leflunomide Sales Value and Growth Rate (2017-2028)
-
Table Europe Leflunomide Sales Volume, by Type (2017-2028)
-
Table Europe Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure Europe Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table Europe Leflunomide Sales Volume, by Application (2017-2028)
-
Table Europe Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure Europe Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure Germany Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure UK Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure UK Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure France Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure France Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Italy Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Spain Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Poland Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Russia Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Leflunomide Sales Value and Growth Rate (2017-2028)
-
Table APAC Leflunomide Sales Volume, by Type (2017-2028)
-
Table APAC Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure APAC Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table APAC Leflunomide Sales Volume, by Application (2017-2028)
-
Table APAC Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure APAC Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure China Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure China Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Japan Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure India Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure India Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Leflunomide Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Leflunomide Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Leflunomide Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Leflunomide Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Leflunomide Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Leflunomide Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Leflunomide Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Leflunomide Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Leflunomide Sales Value and Growth Rate (2017-2028)
-
Table HERITAGE Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table HERITAGE Product Profiles, Application and Specification
-
Table HERITAGE Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table ALEMBIC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ALEMBIC Product Profiles, Application and Specification
-
Table ALEMBIC Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table HUITIAN Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table HUITIAN Product Profiles, Application and Specification
-
Table HUITIAN Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Apote Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Apote Product Profiles, Application and Specification
-
Table Apote Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table MERRO Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MERRO Product Profiles, Application and Specification
-
Table MERRO Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table YABANG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table YABANG Product Profiles, Application and Specification
-
Table YABANG Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Product Profiles, Application and Specification
-
Table Teva Leflunomide Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
